FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385106008: Conventional release solution for cutaneous spray (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479368014 Cutaneous solution spray en Synonym Active Entire term case insensitive SNOMED CT core module
3634262014 Conventional release solution for cutaneous spray (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634263016 Conventional release solution for cutaneous spray en Synonym Active Entire term case insensitive SNOMED CT core module
53208601000001117 Cutaneous spray solution en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release solution for cutaneous spray Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Is a Conventional release cutaneous solution false Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Has dose form administration method Spray true Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Has basic dose form Solution true Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Is a Conventional release cutaneous spray true Inferred relationship Existential restriction modifier
Conventional release solution for cutaneous spray Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Diclofenac 4% cutaneous spray Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Mobigel Paineze 4% spray (Goldshield Pharmaceuticals Ltd) 15 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Mobigel 4% spray (Goldshield Pharmaceuticals Ltd) 30 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Diclofenac 4% cutaneous spray 30 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Mobigel Paineze 4% spray (Goldshield Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Diclofenac 4% cutaneous spray 15 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Mobigel 4% spray (Goldshield Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Dimeticone 4% cutaneous spray Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Hedrin 4% spray (Thornton & Ross Ltd) Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Dimeticone 4% cutaneous spray 120 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Hedrin 4% spray (Thornton & Ross Ltd) 120 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Voltarol Active 4% spray (Novartis Consumer Health UK Ltd) Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Voltarol Active 4% spray (Novartis Consumer Health UK Ltd) 15 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Dimeticone 4% cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Diclofenac 4% cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Mobigel Paineze 4% spray (Goldshield Pharmaceuticals Ltd) Has manufactured dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Voltarol Active 4% spray (Novartis Consumer Health UK Ltd) Has manufactured dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Mobigel 4% spray (Goldshield Pharmaceuticals Ltd) Has manufactured dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Hedrin 4% spray (Thornton & Ross Ltd) Has manufactured dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Lidocaine 7.5mg/actuation / Prilocaine 2.5mg/actuation cutaneous spray Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Fortacin 150mg/ml / 50mg/ml cutaneous spray (Plethora Solutions Ltd) Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Lidocaine 7.5mg/actuation / Prilocaine 2.5mg/actuation cutaneous spray 5 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Fortacin 150mg/ml / 50mg/ml cutaneous spray (Plethora Solutions Ltd) 5 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Lidocaine 7.5mg/actuation / Prilocaine 2.5mg/actuation cutaneous spray Has manufactured dose form False Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Fortacin 150mg/ml / 50mg/ml cutaneous spray (Plethora Solutions Ltd) Has manufactured dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Fortacin 150mg/ml / 50mg/ml cutaneous spray (Recordati Pharmaceuticals Ltd) Has manufactured dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Fortacin 150mg/ml / 50mg/ml cutaneous spray (Recordati Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier
Fortacin 150mg/ml / 50mg/ml cutaneous spray (Recordati Pharmaceuticals Ltd) 5 ml Has dispensed dose form True Conventional release solution for cutaneous spray Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start